Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice
Kirsten A. Nyrop(University of North Carolina at Chapel Hill), Hyman B. Muss(University of North Carolina at Chapel Hill), Carey K. Anders(Duke University), William A. Wood(University of North Carolina at Chapel Hill), Elizabeth Claire Dees(University of North Carolina at Chapel Hill), Seul Ki Choi(University of Pennsylvania), Jordan T. Lee(University of North Carolina at Chapel Hill), JoEllen C. Speca(University of North Carolina at Chapel Hill), Shlomit Strulov Shachar(Tel Aviv Sourasky Medical Center), Bryce B. Reeve(Duke University Health System), Lisa A. Carey(University of North Carolina at Chapel Hill), Gretchen Kimmick(Johns Hopkins University), Allison M. Deal(Memorial Sloan Kettering Cancer Center), Raquel E. Reinbolt(The Ohio State University), Ethan Basch(UNC Lineberger Comprehensive Cancer Center), Trevor A. Jolly(University of North Carolina at Chapel Hill), Kathryn E. Reeder‐Hayes(University of North Carolina at Chapel Hill), Meghan Karuturi(The University of Texas MD Anderson Cancer Center)
Cited by 100
Related Papers
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
|Journal of Clinical Epidemiology|2010|5.1k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k